Term
|
Definition
- ACE inhibitor
- Prevents angiotensin II activation
- Decr. ADH, BV, BP
|
|
|
Term
|
Definition
- AGII receptor antagnist
- Blocks pro-hypertensive effects of AgII
- Binds AT1 receptor
- Decreased water retention, Na retention
|
|
|
Term
|
Definition
- Alpha adrenergic antagonist
- Competitive; A1 selective
- Can increase CO, usually temporary.
|
|
|
Term
|
Definition
- CaCh antagonist/blocker
- decrease channel activity
- decrease TPR
- Can increase CO; usually temporary
|
|
|
Term
Nitroglycerin
(Glyceryl Trinitrate) |
|
Definition
- Exogenous NO donor
- Not explosive when in drug form
- Multiple routes of administration
- Venous dilation, decr preload
- Uses: acute cardiogenic pulm edema, CHF
- Tolerance does develop
|
|
|
Term
|
Definition
- Exogenous NO donor
- arterial and venous dilation
- Decr preload, decr afterload, decr BP
- Uses: hypertensive emergencies, acute CHF
- IV administration
- Light sensitive; breaks down into cyanide
- Fresh sol'n = slightly brownish, should be discarded if it is dark brown, orange or blue
|
|
|
Term
|
Definition
- PDE 5 Inhibitor
- Increased cGMP = Incr PKG = decr Ca, decr contraction: vasodilation
- Mostly in lungs, corpus cavernosum
- Manage pulmonary hypertension
|
|
|
Term
|
Definition
- Potassium channel activator
- Hyperpolarization = decr CaCh opening, decr Ca entry/contraction
- Decr BP, TPR; rarely used
|
|
|
Term
|
Definition
- Profound arterial dilation
- Decr IP3 induced calcium release
- Rarely used for hypertensive crises; reflex tachycardia (baroreceptors), fluid retention (use with diuretic)
- Used with mitral insufficiency (decr afterload, decr mitral regurg)
|
|
|